Journal of Clinical Oncology | 2021

Decreased enrollment of patients with advanced lobular breast cancer compared to ductal breast cancer in interventional clinical trials.

 
 
 
 
 
 
 
 
 
 
 

Abstract


1092Background: Response Evaluation Criteria in Solid Tumors (RECIST) criteria are often used to measure tumor response in cancer trials, especially in the stage IV setting. However, RECIST require...

Volume 39
Pages 1092-1092
DOI 10.1200/JCO.2021.39.15_SUPPL.1092
Language English
Journal Journal of Clinical Oncology

Full Text